Ruiz León, Ana MaríaCamafort, MiguelSala Vila, AleixGilabert, RosaNúñez, IsabelCastro-Barquero, SaraFitó Colomer, MontserratLamuela Raventós, Rosa Ma.Pintó Sala, XavierGarcia-Arellano, AnaRos Rahola, EmilioEstruch Riba, RamonCasas Rodríguez, Rosa M.2025-10-142025-10-142025-05-010008-6363https://hdl.handle.net/2445/223649The Mediterranean Diet (MeDiet), a healthy, plant-based dietary pattern, is recommended by international scientific organizations for its potential in cardiovascular disease (CVD) prevention.1 However, its underlying mechanisms remain incompletely understood.2 Increased carotid intimamedia thickness (CIMT), plaque height and inflammation are recognized as indicators of cardiovascular risk.3,4 Results of previous studies indicate that following the MeDiet may slow CIMT and carotid plaque progression5 and improve vascular inflammation.6 However, to our knowledge, no published studies have assessed whether changes in inflammatory biomarkers resulting from long-term MeDiet intervention correlate with changes in CIMT and plaque height. We hypothesize that MeDiet’s beneficial impact on atherosclerosis—through improving CIMT and plaque height— correlates with its immunomodulatory effects on inflammation and plaque stability-related molecules3 p.application/pdfengcc by (c) Ruiz León, Ana María, 2025http://creativecommons.org/licenses/by/3.0/es/AterosclerosiMalalties cardiovascularsCuina mediterràniaAtherosclerosisCardiovascular diseasesMediterranean cookinginfo:eu-repo/semantics/article7607152025-10-14info:eu-repo/semantics/openAccess